112 related articles for article (PubMed ID: 13910377)
1. Investigation of the serum properdin levels in neoplastic diseases determined by the bacteriophage neutralization assay.
SEKIGUCHI M; ASHIKAWA K; MOTOYA K; ISHIBASHI Y
Gan; 1962 Jun; 53():129-43. PubMed ID: 13910377
[No Abstract] [Full Text] [Related]
2. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
LAURELL AB; REYN A
Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
[No Abstract] [Full Text] [Related]
3. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
[No Abstract] [Full Text] [Related]
4. [STUDIES ON HOST DEFENSES AGAINST CANCER. 1. ON THE BACTERIOPHAGE NEUTRALIZING ACTIVITY OF SERUMS].
SEKIGUCHI M
Arerugi; 1963; 12():348-57. PubMed ID: 14095328
[No Abstract] [Full Text] [Related]
5. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
LAURELL AB; REYN A
Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
[No Abstract] [Full Text] [Related]
6. The properdin system and immunity. XII. Assay, properties and partial purification of a hydrazine-sensitive serum factor (factor A) in the properdin system.
PENSKY J; WURZ L; PILLEMER L; LEPOW IH
Z Immun exp ther; 1959; 118():329-48. PubMed ID: 14431638
[No Abstract] [Full Text] [Related]
7. The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.
BLUM L; PILLEMER L; LEPOW IH
Z Immun exp ther; 1959; 118():349-57. PubMed ID: 13801696
[No Abstract] [Full Text] [Related]
8. [The properdin level in neoplasms and in malignant blood diseases].
DIOMEDE-FRESA V; FUMAROLA A
Prog Med (Napoli); 1959 May; 15():310-4. PubMed ID: 13816890
[No Abstract] [Full Text] [Related]
9. Interpretation of properdin levels determined by phage neutralization technique.
COWAN KM
Science; 1958 Oct; 128(3327):778-9. PubMed ID: 13592254
[No Abstract] [Full Text] [Related]
10. [Behavior of properdin in the first days of life. Study by bacteriophage neutralization].
CONCA G
Minerva Pediatr; 1959 Sep; 11():992-6. PubMed ID: 13811458
[No Abstract] [Full Text] [Related]
11. RETICULOENDOTHELIAL SYSTEM AND NEOPLASMA.
ISHIBASHI Y
Tohoku J Exp Med; 1964 Feb; 82():42-7. PubMed ID: 14136091
[No Abstract] [Full Text] [Related]
12. [Observations on the determination of properdin by means of bacteriophage neutralization].
PERNIS B; TURRI M
Boll Ist Sieroter Milan; 1958; 37(9-10):414-24. PubMed ID: 13607654
[No Abstract] [Full Text] [Related]
13. [Behavior of the serum properdin level in neoplasms of the uterus].
D'ANTONA N
Boll Soc Ital Biol Sper; 1959 Nov; 35():1382-4. PubMed ID: 13813591
[No Abstract] [Full Text] [Related]
14. [On properdin determination in the serum of rats with rapidly growing inoculation tumors].
KALLENBACH H; THUERIGEN G
Z Gesamte Exp Med; 1960; 133():304-9. PubMed ID: 13750946
[No Abstract] [Full Text] [Related]
15. [The properdin system. Part 1. A modified method for determination of properdin in the serum].
MAASSEN W
Z Immun exp ther; 1960 May; 119():405-14. PubMed ID: 14419242
[No Abstract] [Full Text] [Related]
16. [Variations of properdin in cancer patients].
MARQUES P; DOUSTE-BLAZY L; LLOVERAS J; PUEL J
Bull Assoc Fr Etud Cancer; 1960; 47():479-87. PubMed ID: 13767080
[No Abstract] [Full Text] [Related]
17. [Natural immunity and malignant uterine neoplasms].
DE CECCO L
Quad Clin Ostet Ginecol; 1961 Oct; 16():726-40. PubMed ID: 13884167
[No Abstract] [Full Text] [Related]
18. [The properdin system in normal and pathological tissue].
MARQUES P; DOUSTE-BLAZY L; PUEL J
Bull Assoc Fr Etud Cancer; 1962; 49():84-93. PubMed ID: 14470153
[No Abstract] [Full Text] [Related]
19. [The inhibitory activity of serum against T2r + bacteriophage in relation to properdin].
FRANCQ JC; EYQUEM A; GUYOTJEANNIN N
Ann Inst Pasteur (Paris); 1959 Feb; 96(2):178-83. PubMed ID: 13627583
[No Abstract] [Full Text] [Related]
20. [On the determination of so-called "available properdin" in human serum].
von GRAEVENITZ
Arztl Forsch; 1960 Mar; 14():I/134-6. PubMed ID: 13855870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
